Two randomized control clinical trials reported conflicting effects on bone mineral content (BMC) and bone mineral density (BMD): one trial demonstrated preservation of BMC with GLP-1 use, while the other found no significant difference in BMC or BMD between treatment and control groups
I dont feel any nausea at all
The safety profile of semaglutide 2.4 mg in STEP 5 was consistent with that in other STEP program trials 6,7,9,16,23 , and with the GLP-1 receptor agonist class in general 28
Searching useful medications from TCM which are both anti-epileptic and anti-depressive seems highly possible
In addition, peptide therapy in general may lead to side effects related to the route of administration, which, in the case of ipamorelin, is subcutaneous injection
Learn from Jillian, in person at Luminescence, our first Womens Health & Longevity Summit, in Los Angeles on February 1, 2025